We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation.
- Authors
Russo, Vincenzo; Paccone, Andrea; Rago, Anna; Maddaloni, Valeria; Iafusco, Dario; Proietti, Riccardo; Atripaldi, Umberto; D'Onofrio, Antonio; Golino, Paolo; Nigro, Gerardo
- Abstract
We present the case of a 45-year-old man with atrial fibrillation and morbid obesity (weight 128 kg, height 168 cm, BMI 45.4) who was switched from Warfarin 5 mg once daily to Apixaban 5 mg twice daily because he did not achieve at least 60% of the time in therapeutic range. We performed serial determinations of apixaban plasma concentration (at 2, 6, 12, 24 hrs after intake) showing drug levels within reference range, even when the patient lose weight.
- Subjects
ATRIAL fibrillation; CLINICAL drug trials; WEIGHT loss; MORBID obesity
- Publication
Journal of Blood Medicine, 2020, Vol 11, p77
- ISSN
1179-2736
- Publication type
Article
- DOI
10.2147/JBM.S229526